Navigation Links
A Worldwide Milestone in Cell Analysis - 40 Years of Flow Cytometry
Date:6/18/2009

GORLITZ, Germany, June 18 /PRNewswire/ -- 2009 is the year of the 40th anniversary since the introduction of the worldwide first fluorescence based flow cytometer - the ICP 11.

Today, the German biotechnology company celebrates this anniversary at the Saxonian State Vineyard Castle Wackerbarth near Dresden. For the festive ceremony, CEO Roland Gohde receives 100 guests from the scientific, economical and political society.

In 1968, the fluorescence based cytometry was developed by Professor Dr. Wolfgang Gohde at the University in Muenster and patented in the same year (German patent application DE1815352). Nowadays, flow cytometry has evolved as a standard tool for a broad range of applications in healthcare, microbiology, agroscience, aquaculture and quality control in the industrial field.

Fluorescence based flow cytometry is a standard method for automated and rapid cell analysis and cell enumeration procedures. Using most modern optoelectronics, cells and particles of small size, even in nanometer range, are detected. The cells are marked with specific reagents and excited by one or more laser, consequently the emitted fluorescent signals are collected. With the obtained data, cells can be characterized, classified, quantified and sorted. For HIV monitoring, accompanying the antiretroviral therapy of AIDS patients, it is necessary to determine the number of CD4 cells.

Partec has developed a generation of robust, easy to operate and cost effective flow cytometers that can be operated in resource-poor areas in developing countries. 75 employees are working at the company site in Goerlitz, where the dedicated diagnostic solutions are being developed and manufactured. Partec offers the complete diagnostic package and reagents in the fight against Tb, Malaria and HIV/ AIDS.

   http://www.partec.com

    Claudia Khmel
    Partec GmbH
    Am Flugplatz 13, 02828 Gorlitz
    Fon: +49-(0)3581-8746-0
    c.khmel@partec.com



'/>"/>
SOURCE Partec GmbH
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
3. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
4. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
5. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
6. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
7. REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
8. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
9. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
10. Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide
11. Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/21/2016)... 2016 Unique technology combines ... superior security   Xura, Inc. ... secure digital communications services, today announced it is working ... enterprise customers, particularly those in the Financial Services Sector, ... authentication within a mobile app, alongside, and in combination ...
Breaking Biology News(10 mins):